Cargando…

Circulating tumor DNA detection in lung cancer patients before and after surgery

Circulating tumor DNA (ctDNA) in peripheral blood is a “liquid biopsy” that contains representative tumor information including gene mutations. Additionally, repeated ctDNA samples can be easily obtained to monitor response to treatment and disease progression, which may be especially valuable to lu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Nannan, Lou, Feng, Ma, Yongfu, Li, Jie, Yang, Bo, Chen, Wei, Ye, Hua, Zhang, Jing-Bo, Zhao, Ming-Yu, Wu, Wen-Jun, Shi, Rong, Jones, Lindsey, Chen, Katherine S., Huang, Xue F., Chen, Si-Yi, Liu, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027588/ https://www.ncbi.nlm.nih.gov/pubmed/27641744 http://dx.doi.org/10.1038/srep33519

Ejemplares similares

Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing
por: Chen, Ke-Zhong, et al.
Publicado: (2016)

Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer
por: Yang, Xue, et al.
Publicado: (2016)

Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer
por: Hu, Wenwei, et al.
Publicado: (2017)

Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis
por: Fang, Zengli, et al.
Publicado: (2020)

Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer
por: Lu, Jun, et al.
Publicado: (2019)

Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers
por: Hu, Shuo, et al.
Publicado: (2023)

Circulating tumor DNA predicts the outcome of chemotherapy in patients with lung cancer
por: Zhang, Min, et al.
Publicado: (2021)

Role of circulating tumor DNA in the management of early‐stage lung cancer
por: Zhao, Heng, et al.
Publicado: (2018)

Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients
por: Yang, Ying-Chi, et al.
Publicado: (2018)

Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review
por: Chen, Xiaomin, et al.
Publicado: (2020)

Risk of short- and long-term pulmonary complications should be determined before surgery for tuberculosis-destroyed lung
por: Park, Dong Won, et al.
Publicado: (2023)

Circulating microRNA-422a is associated with lymphatic metastasis in lung cancer
por: Wu, Lina, et al.
Publicado: (2017)

Circulating tumor DNA analysis of metastatic renal cell carcinoma
por: Zhang, Jingbo, et al.
Publicado: (2021)

Myocardial injury before noncardiac surgery
por: Chen, Zhibing, et al.
Publicado: (2023)

Molecular analysis of circulating tumor DNA from breast cancer patients before and after surgery and following adjuvant chemotherapy
por: Zelinova, Katarina, et al.
Publicado: (2020)

Prognostic Significance of Circulating Lymphocyte Subsets Before Treatment in Patients with Nasopharyngeal Carcinoma
por: Shen, De-Song, et al.
Publicado: (2021)

Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer
por: Ai, Bo, et al.
Publicado: (2016)

Distribution of Axial Length before Cataract Surgery in Chinese Pediatric Patients
por: Lin, Haotian, et al.
Publicado: (2016)

Quantitative Detection of Circulating Nucleophosmin Mutations DNA in the Plasma of Patients with Acute Myeloid Leukemia
por: Quan, Jing, et al.
Publicado: (2015)

LincRNA FEZF1-AS1 contributes to the proliferation of LAD cells by silencing p57 expression
por: Jin, Shuai, et al.
Publicado: (2017)

Comprehensive analysis of genomic alterations detected by next-generation sequencing-based tissue and circulating tumor DNA assays in Chinese patients with non-small cell lung cancer
por: Yang, Hua, et al.
Publicado: (2019)

An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses
por: Wang, Guan, et al.
Publicado: (2020)

Detection of circulating tumor DNA from non‐small cell lung cancer brain metastasis in cerebrospinal fluid samples
por: Ma, Chunhua, et al.
Publicado: (2020)

Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review
por: Schraa, Suzanna J., et al.
Publicado: (2022)

Clinical evaluation of the rapid recovery of patients who underwent video-assisted thoracoscopic lung surgery under non-intubated anesthesia
por: Cai, Lin-Sheng, et al.
Publicado: (2021)

Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment
por: Förnvik, Daniel, et al.
Publicado: (2019)

Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer
por: Yuan, Shu‐Qiang, et al.
Publicado: (2023)

Stereopsis before and after Inferior Oblique Weakening Surgery
por: Seol, Bo Ram, et al.
Publicado: (2018)

Five Technologies for Detecting the EGFR T790M Mutation in the Circulating Cell-Free DNA of Patients With Non-small Cell Lung Cancer: A Comparison
por: Chen, Yi-Lin, et al.
Publicado: (2019)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases
por: Bai, Kaixuan, et al.
Publicado: (2023)

Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer
por: Shields, Misty Dawn, et al.
Publicado: (2022)

Monitoring colorectal cancer following surgery using plasma circulating tumor DNA
por: Sun, Xiao, et al.
Publicado: (2018)

Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol for a non-inferiority randomized controlled trial (SNEC trial)
por: Guan, Jun, et al.
Publicado: (2021)

Mendelian randomization study indicates lack of causal associations between iron status and lung cancer
por: Qin, Hong, et al.
Publicado: (2022)

Frequent Mutations in EGFR, KRAS and TP53 Genes in Human Lung Cancer Tumors Detected by Ion Torrent DNA Sequencing
por: Cai, Xin, et al.
Publicado: (2014)

Dynamic changes of circulating tumour DNA in surgical lung cancer patients: protocol for a prospective observational study
por: Chen, Kezhong, et al.
Publicado: (2018)

Multidimensional Cell-Free DNA Fragmentomic Assay for Detection of Early-Stage Lung Cancer
por: Wang, Siwei, et al.
Publicado: (2022)

Circulating tumour cells and circulating cell-free DNA in patients with lung cancer: a comparison between thoracotomy and video-assisted thoracoscopic surgery
por: Katopodis, Periklis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qa4dvg2sgkgefskce5312hpv2l